A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma
Ohmachi, Ken, Ogura, Michinori, Suehiro, Youko, Ando, Kiyoshi, Uchida, Toshiki, Choi, Ilseung, Ogawa, Yoshiaki, Kobayashi, Miki, Fukino, Koichi, Yokoi, Yuki, Okamura, JunJournal:
International Journal of Hematology
DOI:
10.1007/s12185-019-02635-9
Date:
March, 2019
File:
PDF, 884 KB
2019
File converter
More search results
More benefits 
